Business Wire

CA-FORESCOUT

Share
Forescout's New Risk and Exposure Management Solution Delivers Streamlined, Quantitative Approach to Cyber Asset Risk Management

Forescout, a global leader in cybersecurity, today unveiled Risk and Exposure Management, its cloud-native product designed to collate all data sources associated with an enterprise’s connected assets and calculate a unique multifactor risk score for each asset, offering a more intuitive and quantitative approach to risk prioritization.

Enterprises’ attack surfaces are expanding daily given the technology and business dynamics at play. Security teams realize that existing approaches to cyber asset management can’t effectively scale to meet the diversity of asset types or track configuration and risk posture changes for their assets, making it exceedingly more difficult to conduct expeditiously any incident analysis. The new Risk and Exposure Management solution addresses this challenge by tracking the changes to posture on a unique status-over-time view for every individual asset and enables security teams to act on intuitive cyber risk intelligence, through security workflow automation driven by the Forescout Platform.

According to Forrester, CISOs are readily seeking new approaches to attack surface management that not only better support their teams, but also prove to their boards how they’re reducing risk exposure based on the effectiveness of their security investments. The analyst firm also found that “Among security decision-makers, 73% report that their firm is adopting attack surface management; a further 15% plan to implement it in the next 12 months.”1

“Enterprises require a simplified way to maintain both real-time and persistent asset intelligence for every asset – managed or unmanaged, physical or virtual, including OT/ICS, IoT devices and specialty subsets such as medical devices,” said Barry Mainz, Forescout CEO and President. “We’ve invested heavily in the Forescout Platform, and the enhancements we are making with the availability of Forescout® Risk and Exposure Management provide that intelligence to help security teams effectively prove a reduction in risk posture of their enterprises’ evolving attack surfaces.”

The use cases and benefits of Forescout Risk and Exposure Management are:

  • Cybersecurity Asset Management: Discover and classify every device across any environment (90 days retention) to help IT security teams leverage asset context and status trends to streamline their operations.
  • Persistent Asset Risk Intelligence: Gain situational awareness of cybersecurity risk posture based on exposure from vulnerabilities and misconfiguration with a unique multifactor risk score.
  • Accelerated Incident Response: Leverage historical asset context to aid analysts’ proactive investigation of risks and reactive response to incidents and events to help minimize the blast radius and reduce mean-time-to-resolution (MTTR).
  • Enhanced IoT Security: Leverage high-fidelity IoT classification through non-disruptive, passive discovery techniques for deployment flexibility, with real-time identification of xIoT vulnerabilities to help security teams understand the attack surface and prioritize response actions.
  • Enhanced Medical Device Security: Clear and concise risk assessment of each connected medical device based on known exposures, attack potential and operational criticality, with insights into FDA class and recall status, to help ensure security without impacting patient care.

In leveraging this product’s capabilities, enterprises can feasibly obtain comprehensive asset intelligence and build a solid foundation for cyber asset attack surface management.

To learn more about the importance of adopting Forescout Risk and Exposure Management, please visit www.forescout.com/products/rem/ and sign up for a demo www.forescout.com/rem.

About Forescout

Forescout Technologies, Inc., a global cybersecurity leader, continuously identifies, protects and helps ensure the compliance of all managed and unmanaged connected cyber assets – IT, IoT, IoMT and OT. For more than 20 years, Fortune 100 organizations and government agencies have trusted Forescout to provide vendor-agnostic, automated cybersecurity at scale. The Forescout® Platform delivers comprehensive capabilities for network security, risk and exposure management, and extended detection and response. With seamless context sharing and workflow orchestration via ecosystem partners, it enables customers to more effectively manage cyber risk and mitigate threats. To learn more, visit www.forescout.com

1 Forrester The State Of Vulnerability Risk Management, 2023 Report - March 15, 2023

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230801736644/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

SBC Medical added to membership of Russell 3000® Index28.6.2025 01:30:00 CEST | Press release

SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical”), a global franchise and provider of services for aesthetic clinics, has been added as a member of the broad-market Russell 3000® Index, effective after the US market opens on June 30, as part of the 2025 Russell indexes reconstitution. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250608244276/en/ Yoshiyuki Aikawa-Director (Chairman), CEO Membership in the Russell 3000® Index, which remains in place for one year, means automatic inclusion in the large-cap Russell 1000® Index or small-cap Russell 2000®Index as well as the appropriate growth and value style indexes. Russell indexes are widely used by investment managers and institutional investors for index funds and as benchmarks for active investment strategies. According to the data as of the end of June 2024, about $10.6 trillion in assets are benchmarked against the Russell US indexes, which belong to

Altimetrik and SLK Software Join Forces to Create an AI-First Engineering Services Powerhouse27.6.2025 22:44:00 CEST | Press release

Altimetrik, a pure-play AI, Data and Digital engineering solutions company, today announced the signing of a definitive agreement to acquire SLK Software (“SLK”), a global technology services firm focused on delivering AI, intelligence automation and analytics solutions. The acquisition will further strengthen Altimetrik’s end-to-end enablement services and expand its customer reach, with a clear path to accelerate towards Altimetrik’s goal of reaching $1billion in annual revenue. The transaction remains subject to customary closing conditions and is expected to close in the second half of 2025. Financial details were not disclosed. Founded in 2000, SLK is recognized as a leader in the tech industry, and for its commitment to create innovative digital solutions. This strategic acquisition will significantly enhance the scale of Altimetrik’s capabilities, bringing together Altimetrik’s AI-first, platform-native engineering model and SLK’s full technology services stack that will further

Andersen Consulting udvider sine kompetencer inden for forretningstransformation med tilføjelsen af The Clearing27.6.2025 16:48:00 CEST | Pressemeddelelse

Andersen Consulting udbygger sin platform med samarbejdsfirmaet The Clearing, som er en managementkonsulentvirksomhed med speciale i organisatorisk omstilling og lederudvikling. The Clearing blev stiftet i 2009 og rådgiver kunder om komplekse udfordringer ved at afstemme ledelse, strategi, kultur og drift. Firmaet arbejder med føderale agenturer, virksomheder og nonprofitorganisationer med henblik på at skabe målbare forandringer på tværs af forskellige interessenter til gavn for en leders vision og strategi. Med dyb erfaring inden for flere sektorer, herunder national sikkerhed, sundhedspleje og finansielle tjenester, leder The Clearings unikke blanding af talent med ekspertise inden for organisationsudvikling, dataanalyse og visuel rådgivning forretningstransformationer i stor skala og arbejder sammen med kunder og eksperter for at sikre, at rådgivning omsættes til implementering. "Vi leverer transformative resultater, der ikke kun er i overensstemmelse med strategiske mål, men også

PRD Therapeutics Announces Initiation of First-in-Human Study for PRD00127.6.2025 16:00:00 CEST | Press release

PRD Therapeutics, Inc., a clinical stage company focused on the development of novel lipid metabolism regulators targeting homozygous familial hypercholesterolemia (HoFH) and metabolic dysfunction associated fatty liver disease (MASH/MASLD), today announced that the company recently initiated dosing in a First-in-Human (FIH) clinical trial of PRD001, a first-in-class SOAT2 (formerly known as ACAT2) selective inhibitor. “We are excited to initiate dosing in this clinical trial of PRD001. Many clinical trials have been conducted on SOAT1/2 dual or SOAT1 selective inhibitors, but this is the first clinical trial of an SOAT2 selective inhibitor” said Kanji Hosoda, Ph.D., CEO and co-founder of PRD Therapeutics. “Several results with SOAT1 or 2 knockout mice have been published, suggesting that knocking out or inhibiting only SOAT2 is crucial to demonstrate safety and efficacy. PRD001 is the world's first and only SOAT2-selective inhibitor and is expected to exhibit safety and efficacy in hu

STEMCELL Technologies Introduces STEMprep™ Tissue Dissociator System to Accelerate Research Discoveries27.6.2025 14:00:00 CEST | Press release

New instrument automates tissue processing for researchers in cancer, immunology and other science fields To help scientists accelerate their workflows, STEMCELL Technologies has commercially launched the STEMprep™ Tissue Dissociator System—a new benchtop instrument that automates, standardizes, and streamlines tissue dissociation, the process of breaking down tissue samples into single-cell suspensions for research purposes. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250627342791/en/ To help scientists accelerate their workflows, STEMCELL Technologies has commercially launched the STEMprep™ Tissue Dissociator System—a new benchtop instrument that automates, standardizes, and streamlines tissue dissociation, the process of breaking down tissue samples into single-cell suspensions for research purposes. “Tissue dissociation is incredibly important for making advancements in research fields, like cancer and immunology, yet

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye